Aptose Biosciences (TSE:APS) Stock Crosses Below Two Hundred Day Moving Average – Here’s Why

Aptose Biosciences Inc. (TSE:APS) (NASDAQ:APTO)’s share price crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of C$11.11 and traded as low as C$5.39. Aptose Biosciences shares last traded at C$5.46, with a volume of 708 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Alliance Global Partners raised Aptose Biosciences to a “strong-buy” rating in a report on Thursday, February 27th.

Aptose Biosciences Trading Up 5.6 %

The firm has a market capitalization of C$243.71 million, a price-to-earnings ratio of -1.13 and a beta of 1.36. The company has a quick ratio of 5.41, a current ratio of 1.05 and a debt-to-equity ratio of -117.37. The firm’s 50 day moving average is C$7.18 and its 200 day moving average is C$11.04.

About Aptose Biosciences

Aptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies.